| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 855,700 | 803,900 | 891,100 | 846,900 | | Cost of Revenue | 551,300 | 521,800 | 597,800 | 597,000 | | | Gross Profit | 304,400 | 282,100 | 293,300 | 249,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 243,500 | 240,000 | 279,600 | 260,100 | | Non Recurring |
-
|
-
|
-
| 838,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,900 | 42,100 | 13,700 | (848,600) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,700 | (1,300) | 900 | 1,200 | | Earnings Before Interest And Taxes | 61,300 | 40,600 | 14,300 | (847,700) | | Interest Expense | 14,200 | 20,500 | 13,800 | 12,800 | | Income Before Tax | 47,100 | 20,100 | 500 | (860,500) | | Income Tax Expense | 16,500 | 7,000 | 200 | (37,700) | | Minority Interest | (200) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,400 | 13,100 | 300 | (822,800) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (100) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,400 | 13,100 | 300 | (822,900) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,400 | $13,100 | $300 | ($822,900) |
|
0.29% Nasdaq 
Income Statement
